Transcatheter aortic and mitral valve interventions: Update 2010

Interventional Cardiology

Volumn 2, Issue 4, 2010, Pages 513-523

  Conradi, Lenard ^a   Treede, Hendrik ^a   Franzen, Olaf ^a   Seiffert, Moritz ^a   Baldus, Stephan ^a   Schirmer, Johannes ^a   Meinertz, Thomas ^a   Reichenspurner, Hermann ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

aortic stenosis; aortic valve replacement; mitral regurgitation; mitral valve repair; percutaneous; transcatheter

Indexed keywords

ANNULOPLASTY; CONGESTIVE HEART FAILURE; CORONARY SINUS; CORONARY STENT; DEVICE; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; HIGH RISK PATIENT; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; PRIORITY JOURNAL; PROSTHESIS; REVIEW;

EID: 77956159169     PISSN: 17555302     EISSN: 17555310     Source Type: Journal    
DOI: 10.2217/ica.10.47     Document Type: Review

References (56)

1. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B: Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1(8472), 63-67 (1986).
2. Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N: Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J. Thorac. Cardiovasc. Surg. 87(3), 394-402 (1984).
3. Jabbour RJ, Dick R, Walton AS: Aortic balloon valvuloplasty-review and case series. Heart Lung Circ. 17(Suppl. 4), S73-S81 (2008).
4. Conradi L, Reichenspurner H: Review on balloon aortic valvuloplasty: a surgeon's perspective in 2008. Clin. Res. Cardiol. 97(5), 285-287 (2008).
5. Rifaie O, Abdel-Dayem MK, Ramzy A et al.: Percutaneous mitral valvotomy versus closed surgical commissurotomy. Up to 15 years of follow-up of a prospective randomized study. J. Cardiol. 53(1), 28-34 (2009).
6. Bonow RO, Carabello BA, Chatterjee K et al.: 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118(15), E523-E661 (2008).
7. Brown JM, O'Brien SM, Wu C, Sikora JA, Griffth BP, Gammie JS: Isolated aortic valve replacement in north america comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the society of thoracic surgeons national database. J. Thorac. Cardiovasc. Surg. 137(1), 82-90 (2009).
8. Kolh P, Kerzmann A, Honore C, Comte L, Limet R: Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur. J. Cardiothorac. Surg. 31(4), 600-606 (2007).
9. Collart F, Feier H, Kerbaul F et al.: Valvular surgery in octogenarians: operative risks factors, evaluation of EuroSCORE and long term results. Eur. J. Cardiothorac. Surg. 27(2), 276-280 (2005).
10. Likosky DS, Sorensen MJ, Dacey LJ et al.: Long-term survival of the very elderly undergoing aortic valve surgery. Circulation 120(Suppl. 11), S127-S133 (2009).
11. Iung B, Cachier A, Baron G et al.: Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur. Heart J. 26(24), 2714-2720 (2005).
12. Cribier A, Eltchaninoff H, Bash A et al.: Percutaneous transcatheter implantation of an aortic valve prosthesis for calcifc aortic stenosis: frst human case description. Circulation 106(24), 3006-3008 (2002).
13. Vahanian A, Alferi O, Al-Attar N et al.: Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 29(11), 1463-1470 (2008).
14. Filsouf F, Rahmanian PB, Castillo JG, Chikwe J, Silvay G, Adams DH: Excellent early and late outcomes of aortic valve replacement in people aged 80 and older. J. Am. Geriatr. Soc. 56(2), 255-261 (2008).
15. Lange R, Schreiber C, Gotz W et al.: First successful transapical aortic valve implantation with the corevalve revalving system: a case report. Heart Surg. Forum 10(6), E478-E479 (2007).
16. Schofer J, Schluter M, Treede H et al.: Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: a frst-in-man feasibility and safety study. Circ. Cardiovasc. Interv. 1(2), 126-133 (2008).
17. Treede H, Tübler T, Reichenspurner H et al.: Six-months results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve. J. Thorac. Cardiovasc. Surg. DOI: 10.1016/j. jtcvs.2010.01.017 (2010) (Epub ahead of print).
18. Falk V, Schwammenthal EE, Kempfert J et al.: New anatomically oriented transapical aortic valve implantation. Ann. Thorac. Surg. 87(3), 925-926 (2009).
19. Webb JG, Chandavimol M, Thompson CR et al.: Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113(6), 842-850 (2006).
20. Walther T, Falk V, Borger MA et al.: Minimally invasive transapical beating heart aortic valve implantation-proof of concept. Eur. J. Cardiothorac. Surg. 31(1), 9-15 (2007).
21. Lichtenstein SV, Cheung A, Ye J et al.: Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 114(6), 591-596 (2006).
22. Bleiziffer S, Ruge H, Mazzitelli D et al.: Survival after transapical and transfemoral aortic valve implantation: talking about two different patient populations. J. Thorac. Cardiovasc. Surg. 138(5), 1073-1080 (2009).
23. Seiffert M, Treede H, Franzen O et al.: Mortality after transapical aortic valve implantation is not related to the procedure but to the preoperative risk. Thorac. Cardiovasc. Surg. 58(Suppl. 1), S116 (2010).
24. Kempfert J, Falk V, Schuler G et al.: Dyna-CT during minimally invasive off-pump transapical aortic valve implantation. Ann. Thorac. Surg. 88(6), 2041 (2009).
25. Ruge H, Lange R, Bleiziffer S et al.: First successful aortic valve implantation with the corevalve revalving system via right subclavian artery access: a case report. Heart Surg. Forum 11(5), E323-E324 (2008).
26. Cribier A, Litzler PY, Eltchaninoff H et al.: Technique of transcatheter aortic valve implantation with the Edwards-Sapien heart valve using the transfemoral approach. Herz 34(5), 347-356 (2009).
27. Walther T, Dewey T, Borger MA et al.: Transapical aortic valve implantation: step by step. Ann. Thorac. Surg. 87(1), 276-283 (2009).
28. Van Brabandt H, Neyt M: Safety of percutaneous aortic valve insertion. A systematic review. BMC Cardiovasc. Disord. 9, 45 (2009).
29. Del Valle-Fernández, Martinez CA, Ruiz CE: Transcatheter aortic valve implantation. Cardiol. Clin. 28(1), 155-168 (2010).
30. Grube E, Schuler G, Buellesfeld L et al.: Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J. Am. Coll. Cardiol. 50(1), 69-76 (2007).
31. Webb JG, Pasupati S, Humphries K et al.: Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116(7), 755-763 (2007).
32. Walther T, Kempfert J, Borger M et al.: Transapical aortic valve implantation-current results. Thorac. Cardiovasc. Surg. 58(Suppl. 1), S27 (2010).
33. Bleiziffer S, Ruge H, Mazzitelli D et al.: Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team. Eur. J. Cardiothorac. Surg. 35(4), 615-620 (2009).
34. Rodés-Cabau J, Webb JG, Cheung A et al.: Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J. Am. Coll. Cardiol. 55(11), 1080-1090 (2010).
35. Piazza N, Grube E, Gerckens U et al.: Procedural and 30-days outcomes following transcatheter aortic valve implantation using the third generation (18Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 4(2), 242-249 (2008).
36. Grube E, Laborde JC, Gerckens U et al.: Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg frst-in-man study. Circulation 114(15), 1616-1624 (2006).
37. Piazza N, Onuma Y, Jesserun E et al.: Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc. Intervent. 1(3), 310-316 (2008).
38. Sinhal A, Altwegg L, Pasupati L et al.: Atrioventricular block after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc. Interv. 1(3), 105-109 (2008).
39. Masson JB, Kovac J, Schuler G et al.: Transcatheter aortic valve implantation: review of the nature, management and avoidance of procedural complications. JACC Cardiovasc. Interv. 2(9), 811-820 (2009).
40. Carpentier A: Cardiac valve surgery-the "French correction". J. Thorac. Cardiovasc. Surg. 86(3), 323-337 (1983).
41. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL: Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 91(4), 1022-1028 (1995).
42. David TE: Outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Semin Thorac. Cardiovasc. Surg. 19(2), 116-120 (2007).
43. Bach DS, Bolling SF: Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty. Am J. Cardiol. 78(8), 966-969 (1996).
44. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM: Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J. Am. Coll. Cardiol. 45(3), 381-387 (2005).
45. Mihaljevic T, Lam BK, Rajeswaran J et al.: Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J. Am. Coll. Cardiol. 49(22), 2191-2201 (2007).
46. Lansac E, Di Centa I, Al Attar N et al.: Percutaneous mitral annuloplasty through the coronary sinus: an anatomic point of view. J. Thorac. Cardiovasc. Surg. 135(2), 376-381 (2008).
47. Choure AJ, Garcia MJ, Hesse B et al.: In vivo analysis of the anatomical relationship of coronary sinus to mitral annulus and left circumfex coronary artery using cardiac multidetector computed tomography: implications for percutaneous coronary sinus mitral annuloplasty. J. Am. Coll. Cardiol. 48(10), 1938-1945 (2006).
48. Tops LF, van de Veire NR, Schuijf JD et al.: Noninvasive evaluation of coronary sinus anatomy and its relation to the mitral valve annulus: implications for percutaneous mitral annuloplasty. Circulation 115(11), 1426-1432 (2007).
49. Schofer J, Siminiak T, Haude M et al.: Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the carillon mitral annuloplasty device european union study. Circulation 120(4), 326-333 (2009).
50. Kuck KH, Webb JG, Harnek J, Buller C, Pauschinger C, Tiefenbacher C: Percutaneous treatment of functional mitral regurgitation: interim evolution study results with the Monarc system. Am. J. Cardiol. 100, L58 (2007).
51. Sack S, Kahlert P, Bilodeau L et al.: Percutaneous transvenous mitral annuloplasty: initial human experience with a novel coronary sinus implant device. Circ. Cardiovasc. Interv. 2(4), 277-284 (2009).
52. Alferi O, Maisano F, De Bonis M et al.: The double-orifce technique in mitral valve repair: a simple solution for complex problems. J. Thorac. Cardiovasc. Surg. 122(4), 674-681 (2001).
53. Rogers JH, Yeo KK, Carroll JD et al.: Late surgical mitral valve repair after percutaneous repair with the MitraClip™ system. J. Card. Surg. 24(6), 677-681 (2009).
54. Feldman T, Wasserman HS, Herrmann HC et al.: Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I clinical trial. J. Am. Coll. Cardiol. 46(11), 2134-2140 (2005).
55. Feldman T, Mauri L, Foster E et al.: Endovascular valve edge-to-edge repair study randomized clinical trial: primary safety and effcacy endpoints. Presented at: American College of Cardiology 59th Annual Scientifc Session. Atlanta, GA, USA, 14-16 March 2010.
56. Franzen O, Baldus S, Rudolph V et al.: Acute outcomes of mitraclip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur. Heart J. 31(11), 1373-1381 (2010).